CDKN2A and glioma: In two cases (cases one and three), tumors harbored a homozygous CDKN2A/B deletion, consistent with a previously published series and observations in xenograft models, suggesting a dependency of MET fusion-induced tumorigenesis on additional cell cycle regulation impairing genetic lesions in pediatric glioma [19].